The multiple roles of computational chemistry in fragment-based drug design-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The multiple roles of computational chemistry in fragment-based drug design

Published:2009-06-17 Issue:8 Volume:23 Page:459-473
ISSN:0920-654X
Container-title:Journal of Computer-Aided Molecular Design
language:en
Short-container-title:J Comput Aided Mol Des

Author:

Law Richard,Barker Oliver,Barker John J.,Hesterkamp Thomas,Godemann Robert,Andersen Ole,Fryatt Tara,Courtney Steve,Hallett Dave,Whittaker Mark

Publisher

Springer Science and Business Media LLC

Subject

Physical and Theoretical Chemistry,Computer Science Applications,Drug Discovery

Link

http://link.springer.com/content/pdf/10.1007/s10822-009-9284-1.pdf

Reference93 articles.

1. Agnelli G, Haas S, Ginsberg JS, Krueger KA, Dmitrienko A, Brandt JT (2007) A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement. J Thromb Haemost 5(4):746–753. doi: 10.1111/j.1538-7836.2007.02436.x

2. Albert JS (2007) Editorial: fragment-based drug discovery. Curr Top Med Chem 7(6):1543. doi: 10.2174/156802607782341127

3. Albert JS, Blomberg N, Breeze AL, Brown AJ, Burrows JN, Edwards PD, Folmer RH, Geschwindner S, Griffen EJ, Kenny PW et al (2007) An integrated approach to fragment-based lead generation: philosophy, strategy and case studies from AstraZeneca’s drug discovery programmes. Curr Top Med Chem 7(16):1600–1629. doi: 10.2174/156802607782341091

4. Alex AA, Flocco MM (2007) Fragment-based drug discovery: what has it achieved so far? Curr Top Med Chem 7(16):1544–1567. doi: 10.2174/156802607782341082

5. Artis DR, Lin JJ, Zhang C, Wang W, Mehra U, Perreault M, Erbe D, Krupka HI, England BP, Arnold J et al (2009) Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent. Proc Natl Acad Sci USA 106(1):262–267. doi: 10.1073/pnas.0811325106

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence in Drug Identification and Validation: A Scoping Review;Drug Research;2024-06

2. Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancer;BJC Reports;2024-01-23

3. Human models as new tools for drug development and precision medicine;Phenotyping of Human iPSC-derived Neurons;2023

4. Coming of Age of Computational Chemistry from a Resilient Past to a Promising Future;Israel Journal of Chemistry;2021-11-10

5. High-Throughput Screening for the Discovery of Enzyme Inhibitors;Journal of Medicinal Chemistry;2020-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3